CliffBio
small molecule

VASOPRESSIN IN SODIUM CHLORIDE 0.9%

VASOPRESSIN

Loss of exclusivity—loss of exclusivity
CompanyLong Grove →See this company's full patent-cliff portfolio

Drug detail

Brand nameVASOPRESSIN IN SODIUM CHLORIDE 0.9%
Active ingredientVASOPRESSIN
Strength50UNITS/50ML (1UNIT/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJuly 2024
Marketing statusDISCN

More from Long Grove

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.